MedPath

Sleep-disordered Breathing and Perioperative Atrial Fibrillation in Cardiac Surgery

Conditions
Coronary Artery Disease
Elective Coronary Artery Bypass Grafting (CABG) Surgery
Sleep-disordered Breathing (SDB)
Atrial Fibrillation
Interventions
Other: Stratification, no intervention
Registration Number
NCT02877745
Lead Sponsor
Michael Arzt
Brief Summary

In patients undergoing elective coronary artery bypass grafting (CABG) surgery, coronary artery disease, sleep-disordered breathing (SDB), atrial fibrillation (AF) perioperative atrial fibrillation and complications will be assessed. The primary objective is to determine, whether SDB patients have a higher rate of Major Adverse Cardiac and Cerebrovascular Events (MACCE) within 30 days after surgery compared to those without SDB.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1200
Inclusion Criteria
  • Patients undergoing elective CABG surgery at the Department of Cardiac and Thoracic Surgery, University Hospital Regensburg.
  • Written informed consent
Exclusion Criteria
  • Preoperative use of inotropes or intra aortic balloon pump
  • Severe obstructive pulmonary disease
  • Patients on oxygen therapy, nocturnal positive airway pressure support or mechanical ventilation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
SDBStratification, no interventionapnea-hyponea index \>=15/hour
no SDBStratification, no interventionapnea-hyponea index \<15/hour
Primary Outcome Measures
NameTimeMethod
Major Adverse Cardiac and Cerebrovascular Events (MACCE)30 days

periprocedural and late myocardial infarction (MI), non-fatal stroke and transitory ischemic attack (TIA) as well as all-cause mortality

Secondary Outcome Measures
NameTimeMethod
postoperative atrial fibrillation (POAF)30 days after CABG surgery

assessed by ECG

Strokewithin 1 year after CABG surgery

assessed by questionnaire

MACCEwithin 1 and 2 years after CABG surgery

assessed by questionnaire

Major pulmonary complicationswithin 30 days as well as 1 and 2 years

assessed by questionnaire

Trial Locations

Locations (1)

Department of Internal Medicine II, University Hospital

🇩🇪

Regensburg, Germany

© Copyright 2025. All Rights Reserved by MedPath